Equities research analysts expect that Perrigo Company PLC (NYSE:PRGO) will announce earnings of $1.07 per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Perrigo’s earnings, with estimates ranging from $1.02 to $1.14. Perrigo posted earnings of $1.26 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 15.1%. The firm is scheduled to report its next earnings report on Tuesday, May 14th.
On average, analysts expect that Perrigo will report full-year earnings of $4.47 per share for the current year, with EPS estimates ranging from $3.93 to $5.04. For the next year, analysts anticipate that the firm will post earnings of $4.83 per share, with EPS estimates ranging from $4.30 to $5.52. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that follow Perrigo.
Get Perrigo alerts:Perrigo (NYSE:PRGO) last released its quarterly earnings data on Wednesday, February 27th. The company reported $0.97 EPS for the quarter, missing the Zacks’ consensus estimate of $1.00 by ($0.03). Perrigo had a net margin of 2.54% and a return on equity of 11.32%. The firm had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.18 billion. During the same quarter in the prior year, the company earned $1.28 EPS. Perrigo’s quarterly revenue was down 6.5% on a year-over-year basis.
A number of brokerages recently weighed in on PRGO. Berenberg Bank lowered shares of Perrigo from a “buy” rating to a “hold” rating and reduced their target price for the stock from $100.00 to $72.00 in a research note on Tuesday, November 13th. Morgan Stanley reduced their target price on shares of Perrigo from $77.00 to $67.00 and set a “hold” rating for the company in a research note on Tuesday, November 13th. ValuEngine upgraded shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Friday, November 16th. Wells Fargo & Co reduced their price objective on shares of Perrigo from $77.00 to $64.00 and set a “market perform” rating for the company in a research note on Wednesday, November 14th. Finally, Royal Bank of Canada set a $48.00 price objective on shares of Perrigo and gave the stock a “hold” rating in a research note on Thursday, February 28th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $77.29.
Shares of PRGO traded up $0.99 during trading hours on Monday, reaching $47.49. The stock had a trading volume of 773,154 shares, compared to its average volume of 1,545,659. The company has a quick ratio of 1.26, a current ratio of 1.85 and a debt-to-equity ratio of 0.54. Perrigo has a 52 week low of $36.28 and a 52 week high of $87.69. The stock has a market cap of $6.32 billion, a P/E ratio of 10.44, a P/E/G ratio of 1.81 and a beta of 1.31.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 19th. Investors of record on Friday, March 1st will be paid a $0.19 dividend. The ex-dividend date is Thursday, February 28th. This represents a $0.76 annualized dividend and a yield of 1.60%. Perrigo’s dividend payout ratio (DPR) is currently 16.70%.
Large investors have recently modified their holdings of the stock. Man Group plc boosted its stake in shares of Perrigo by 754.0% in the 3rd quarter. Man Group plc now owns 113,206 shares of the company’s stock valued at $8,015,000 after purchasing an additional 99,950 shares in the last quarter. Amalgamated Bank bought a new stake in Perrigo during the 3rd quarter valued at about $1,144,000. Nisa Investment Advisors LLC increased its stake in Perrigo by 8.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 30,641 shares of the company’s stock valued at $1,187,000 after purchasing an additional 2,400 shares in the last quarter. Atlas Capital Advisors LLC bought a new stake in Perrigo during the 4th quarter valued at about $26,000. Finally, Hsbc Holdings PLC increased its stake in Perrigo by 121.8% during the 3rd quarter. Hsbc Holdings PLC now owns 45,116 shares of the company’s stock valued at $3,194,000 after purchasing an additional 24,776 shares in the last quarter. Institutional investors and hedge funds own 80.93% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Recommended Story: How To Calculate Debt-to-Equity Ratio
Get a free copy of the Zacks research report on Perrigo (PRGO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment